Bill Ackman Turns Philanthropy Into a Biotech Venture Engine

Broad-based equity ownership, Ackman maintained, represents the most effective vehicle for domestic wealth creation. Because standard wage growth does not compound at the historical rate of public equity markets, he argued that expanding direct public access to financial assets remains essential to long-term economic stability.

That private-sector outlook also shapes Ackman’s approach to medical research. The Brain Research Rehabilitation Institute will use philanthropic capital to fund foundational work before spinning successful discoveries—including molecular compounds, medical devices, and clinical treatments—into independent, for-profit commercial enterprises. Staff scientists and researchers will hold equity stakes in those spinouts, following the compensation framework Ackman established at Pershing Square Capital Management.

Ackman finalized the acquisition of a building for the institute after his daughter, Lucy, suffered a brain hemorrhage in February. The personal medical crisis prompted the billionaire founder and chief executive of Pershing Square Capital Management to redirect his family foundation’s resources toward brain injury, stroke rehabilitation, and neurotherapeutics.

The institute’s foundational tier will operate as a nonprofit. That structure is intended to help it recruit academic scientists and establish partnerships with universities and hospital networks that are legally or structurally precluded from working directly with commercial venture funds.

“There are things you can achieve as a nonprofit, like hiring certain people or partnering with institutions that will only work with nonprofits, that would be harder as a for-profit,” Ackman said.

The model targets the translational “valley of death” in life sciences. The federal government routinely finances foundational laboratory research through agencies like the National Institutes of Health, while venture capital funds late-stage clinical startups. The intermediate stage, in which basic laboratory science is translated into viable commercial applications, frequently faces funding shortfalls.

Ackman described the strategy in an interview with Fortune editor-in-chief Alyson Shontell and reporter Jeff John Roberts for the *Fortune 500: Titans and Disruptors of Industry* series. He said the hybrid design circumvents standard market constraints while preserving competitive discipline.

“There’s venture money for healthcare startups, but a lot of basic science research is too far from revenue or a company to attract venture funding. So it has to be government-funded or philanthropic,” Ackman said. “The goal is to use philanthropic capital to build something sustainable using for-profit, capitalist principles.”

The launch represents a strategic shift for the Pershing Square Foundation, which Ackman co-founded in 2006. The foundation has committed nearly $1 billion across international development, education, social enterprise, and cancer research. Ackman said his early philanthropic efforts were influenced by Warren Buffett’s tenet that diversification mitigates risk.

After more than two decades of capital deployment, Ackman concluded that traditional philanthropic grants often fail to create self-sustaining institutions. “I’ve spent a fair amount of time on philanthropy, and it’s vastly less efficient at solving problems than capitalism,” he said. “You create far more jobs through capitalism than through philanthropy.”

He argued that traditional charitable organizations often face structural inefficiencies because they lack market pressures and equity incentives, leaving them vulnerable to mission drift or politicization.

Ackman’s position echoes a broader argument from prominent business leaders who say enterprise creation produces greater societal utility than conventional charity. In May, Amazon founder Jeff Bezos expressed a similar view during an appearance on CNBC’s *Squawk Box*, saying his commercial operations would ultimately generate more social value than his philanthropic contributions.

Bezos committed $10 billion over a decade to the Bezos Earth Fund alongside his wife, Lauren Sánchez Bezos, and has supported conservation initiatives with figures including Leonardo DiCaprio. He has combined private-market operations with substantial charitable distribution pledges.

Ackman’s views on private-sector mechanisms extend to macroeconomic and civic policy. Speaking about urban policy, the New York-based investor criticized regulatory interventions in housing markets, including rent-control expansions advocated by local politicians such as New York State Assembly member Zohran Mamdani.

Roughly half of all apartments in New York City fall under rent-stabilization guidelines, Ackman noted. He said statutory caps on post-renovation rent recoveries have led property owners to keep an estimated 60,000 uninhabitable or unrenovated units off the market. State regulatory processes for major infrastructure and residential developments, he added, routinely face multi-year bureaucratic delays.

Ackman contrasted New York’s constrained supply with Austin, Texas, where permitting deregulation led to construction booms and lower average rents. He also highlighted Florida’s lower-tax regulatory climate.